Tag: Graham Kelly

Noxopharm launches NOXCOVID-1 clinical trial of Veyonda across Europe

pharmanewsdaily- July 1, 2020

Noxopharm, an Australian clinical-stage pharma company, has started the phase 1 NOXCOVID-1 clinical trial for Veyonda in Europe to evaluate the anti-cancer drug candidate as ... Read More